'' joins long list of disease Web domains

Jeff Daniels, coordinating producer

Searching for Ebola news? You may land on Turns out it's for sale, and the guy who owns it is hoping a pharmaceutical company might buy it.

The Cleaning Guys hazmat cleanup company are seen here as they sanitize the apartment where Ebola patient Thomas Eric Duncan was staying before being admitted to a hospital in Dallas.
Getty Images

It's not unusual for big pharmaceutical companies to hold domains for major diseases on the Internet. For example, the and domains are held by Johnson & Johnson, is held by an affiliate of GlaxoSmithKline, and by Pfizer. But who would want to own the domain name

"We've had many inquiries on the domain over the years," according to Jon Schultz, president of Nevada-based Blue String Ventures and the owner of the domain.

Schultz bought in 2008 for an undisclosed sum.

Read MoreOfficials watch and wait after US Ebola death

" would be a great domain for a pharmaceutical company working on a vaccine or cure, a company selling pandemic or disaster-preparedness supplies, or a medical company wishing to provide information and advertise services," Schultz told CNBC in an emailed statement.

"There could be many other applications as well. With so many people concerned about the disease, any advertisement referring people to should get an excellent response."

Schultz, together with his business partner Chris Hood, own other medical or health-related domains, including, and, among others. The company's strategy is to buy "generic domains which we think we can develop or resell later at a profit," said Schultz. "Having seen the movie 'Outbreak,' I was entranced by the subject and couldn't resist buying the domain."

Ebola treatments: What we know
Ebola treatments: What we know

The current asking price for $150,000. However, Schultz said the domain's price "is subject to change as the situation evolves."

He added: "$150,000 is not a tremendous amount for a premium domain. The fact that this is a top news story makes it very reasonable, in our opinion, as many domains sell for seven figures. Just this year sold for $3.1 million and sold for $3.6 million."

Read MoreWhy we haven't cured Ebola yet

DigitalDNA, the domain name broker representing, approached several large pharma firms to gauge interest in buying the domain. It also reached out to several smaller biotech companies, including those with Ebola drugs or treatments in the pipeline. There appears to be interest coming from domain speculators—but not so much from the pharma or bio companies, according to the broker.

It's conceivable, of course, that the life science companies are worried that buying the domain might give a perception of trying to profit from the deadly outbreak. The World Health Organization estimates that more than 3,800 people have died from the virus.

Experimental Ebola drugs outlook
Experimental Ebola drugs outlook

"It might not fit their strategy to generate revenue from treating and curing large-scale diseases," said Rob Frankel, a marketing and branding expert in Los Angeles. "If you talk about cancer, diabetes, flu ... that is driven by scale. Pharma guys aren't being driven by media hype. They'll get behind something with numbers." currently features a link on the home page to donate to Doctors Without Borders, a medical aid charity treating Ebola patients in Africa. There are also links to news articles about the outbreak. In addition, there are also several advertisements, including one linking to "Ebola Books, eBooks and DVDs at"

Read More

Schultz said that Amazon is not an advertiser on the site. "That is actually our advertisement as it is an 'affiliate link.' We have joined Amazon's affiliate program, and if people click on that link and buy a book or DVD, we get a commission on the sale."

Amazon declined to comment.